LAPTM4B and cancer: Overexpression of LAPTM4B-35 promotes antiapoptosis, proliferation, migration, invasion [10, 11] and multidrug resistance of cancer cells [12, 13], and it also elicits oncogenesis of NIH 3T3 cells from mouse fibroblast cell line [14] and L02 cells from normal human liver cell line [15].